Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medarex Inc.

Division of Bristol-Myers Squibb Co.
www.medarex.com

Latest From Medarex Inc.

Honjo, Ono Remain At Loggerheads As Opdivo Dispute Simmers

PD-1 discoverer and the Japanese co-developer of Opdivo remain locked in simmering dispute over patent royalties, with a revised one-off settlement or legal action emerging as possible near-term options.

 

Japan Intellectual Property

Bristol/Celgene A Record-Setting Merger, If It Happens

The mega-merger would be the third largest in biopharma history, but some analysts wonder if other suitors will try to acquire Bristol before the deal closes. Celgene’s partners, and their investors, are concerned about the ramifications.

Business Strategies M & A

Bristol/Celgene A Record-Setting Merger, If It Happens

The $74bn mega-merger would be the third largest in biopharma history, but some analysts wonder if other suitors will try to acquire Bristol before the deal closes.

Business Strategies M & A

Champagne Flows As CTLA-4/PD-1 Pioneers Allison And Honjo Win Nobel Prize

Joint prize for MD Anderson's James Allison and Kyoto University's Tasuku Honjo for checkpoint immunotherapy reflects decades of research and billions of IO dollars for industry.

ImmunoOncology Research & Development
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register